chrisvoncsefalvay/vaers-outcomes huggingface dataset:
A report has been received from a medical rep concerning a female patient. The patient's medical history and concomitant medications were not reported. On 31-Oct-2013, the patient started receiving treatment with nasal FLUMIST (Intranasal). On 11-Feb-2014 patient presented to the doctor's office with influenza A. Action taken with FLUMIST was unknown. The outcome of the event of influenza A was unknown. The report was considered to be non-serious by reporter.
had a resting racing heart over 130 most nights since my vaccinations; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (had a resting racing heart over 130 most nights since my vaccinations) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041C21A and 043B214) for COVID-19 vaccination.     Concurrent medical conditions included Grass allergy, Hypothyroidism since 2006, Allergy to plants, Allergic to cats, Allergy to molds and Dust allergy.   On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HEART RATE INCREASED (had a resting racing heart over 130 most nights since my vaccinations). The patient was treated with THYROID (ARMOUR THYROID) at a dose of 1 mg. At the time of the report, HEART RATE INCREASED (had a resting racing heart over 130 most nights since my vaccinations) outcome was unknown.            No Concomitant medications was reported  Nightly around 9 pm patient experienced a resting rapid heart rate of 110-130 for about 10 min. This happened probably 5 of 7 nights.   Most recent FOLLOW-UP information incorporated above includes: On 21-Sep-2021: added: reporters information, patient details updated, medical history, lot/batch number, start date  of suspected dose
This spontaneous report as received from an unspecified reporter refers to a patient of unknown age and gender. On 17-FEB-2015 the patient was vaccinated with MMR II (route, dose, frequency and lot # not reported) which underwent an excursion (on an unspecified date). This is one of several reports from the same source. Additional information has been requested.
Patient received vaccination on 11 July 2006, the next day noticed arm was red and swollen, approx. 4 inches by 5 inches, area was raised, felt warm.  It was difficult for patient to raise left arm above head.  Also had a temperature of 104 degrees.  Went to the emergency room on 13 July 2006 at 3:30 pm.  Was seen by ER physician.  Prescribed Septra and Non-aspirin tablets for pain.  As of 14 July 2006, the red area has decreased in size, no longer warm and does not itch.
Information has been received from a registered nurse concerning a 20 year old female who on 04-OCT-2007 was vaccinated with a first dose of GARDASIL 0.5 ml IM. Concomitant therapy also given on 04-OCT-2007 included TDAP. On 04-OCT-2007, the patient experienced a migraine and dizziness. The patient sought medical attention by calling the nurse. At the time of reporting, the patient's migraine and dizziness persisted. Additional information has been requested.
pt recvd vax 12noon; 1215PM pt w/blush coloring, swelling to tongue & neck;diff in breathing;had vomiting/dry heaves;inject site: red, golf ball size w/in 20mins;treated w/Epi SC, inhaled albuterol & 02
He received the 1st shot of Moderna vaccine at 8:15 am.  Around 5:00 PM, he experienced chills (was not able to take temperature), nausea, and loss of appetite. This lasted throughout the first evening. No adverse side effects the second day.
sore arm; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was not recovered/not resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. It was reported that the patient received dose of Shingrix and experienced sore arm that had not resolved.
Patient reports having left shoulder/lateral upper arm pain since receiving the vaccine on 9/23/20.  Pain has persisted, ROM slightly limited secondary to pain.  She is going to try alternating warm and cool compresses, over-the-counter naproxen as directed as needed, and physical therapy.
Patient presented with small (less than 1 inch in diameter) patch that looked like an injection site reaction. Patient complained of itchiness at the site. Patient had received the vaccine 7 days ago. Patient mentioned she was allergic to benadryl so she was counseled to apply hydrocortisone 1% with aloe over the injection site and follow up in 2 days with the pharmacy.
sore throat, nonproductive cough, chills, loss of taste, , loss of smell, nasal congestion, sneezing, itchy eyes.        Patient denies headache, fever, shortness of breath, diarrhea, ear pain, sinus congestion, postnasal drainage, chest congestion, chest tightness, chest pain, wheezing, ear fullness.  starting 10/7/21
I experienced flu like symptoms after receiving the vaccine. On 05/07/2021 during a routine CT Scan, the doctor discovered swollen Lung Node that measured 1.9 centimeters which was unable to reached via biopsy. Then, on the 05/20/2021, I had a PET Scan and they mentioned that it could have been from the injection of the vaccine. I had three CT Scans within 3 months and it was finally gone on 08/02/2021. I still have a nighttime cough.
I had a sore arm and tired for one day. I started to feel bad on 06/24/22 feeling like a bad cold. I tested positive on 06/27/2022 for COVID-19 with a PCR test. The home test I took was negative.  I took Mucinex, Tylenol and Night Quil to help with my symptoms.
I had to run for the bathroom with sudden-onset diarrhea. No cramps, not much pain to speak of--just a little. My intestines have cleaned themselves OUT beginning last night and continuing to today (noon). I will be feeling nothing and then suddenly--have to RUN for the bathroom, and don't be late.
Narrative:  Pt 71y male died on 07/11/2021. MD death note indicated death was caused by septic shock secondary to pneumonia. According to intern notes 24hr events following 07/11/2021 include pt worsened overnight, requiring norepi and vasopressin, placed back on ventilator, unable to tolerate CT, and family decided to withdraw care. Vaccines likely not related to cause of death.
BREAKTHROUGH COVID INFECTION. TESTED POSITIVE ON 09/22/2021. PATIENT FULLY VACCINATED ON 02/12/2021.
grandma called reported pt started w/fever yesterday;today fever was 102 R & pt is irritable;no rash, no runny nose;APAP helps to bring fever down;
Guillian Barre Syndrome with malaise, unsteadiness, lower extremity pain and weakness starting in mid Dec 2009 and worsening.  Admitted to Medical Center 01/06/2009, Exam c/w GBS, enhancement of spinal nerve roots on MRI, and CSF protein 527.  Pt had URI in late Nov and early Dec, 2 weeks before onset of sx.  Pt had first dose of H1N1 vaccine in mid-Nov 2009 with PCP and second dose of H1N1 influenza vaccine in mid-Dec 2009.
I was super sneezy and don't have allergies but the sneeze became a deep throated cough with phlegm and I was very tired and the fatigue has been leading up to it and thought I shouldn't go into work and I tested and it was positive. I waited 10 days and visited employee health before I could get cleared to return to work. I also experienced fever and chills on the 1st and 2nd of April and by the following weekend the fever was gone but the fatigue and cough was still there.  I am not able to do as much exercise as I was able to do before having COVID-19.
I woke up this morning with partial black eye near my nose/a partial black eye under area of my eye close to my nose, on my lid; This is a spontaneous report from a contactable consumer or other non hcp (patient). A patient of unspecified age and gender received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration on 24Apr2021 as dose 2, single for COVID-19 immunisation. The patient medical history was not reported. The patient previously received first dose of bnt162b2 via an unspecified route of administration on 02Apr2021 Good Friday, (Batch/Lot Number, Expiry Date were Unknown) as dose 1, single for COVID-19 immunisation. The patient's concomitant medications were not reported. On 25Apr2021, the patient experienced I woke up this morning with partial black eye near my nose/a partial black eye under area of my eye close to my nose, on my lid. The patient reported, got second Pfizer vaccine (Pfizer COVID Vaccine) yesterday (24April2021). The patient was woke up this morning (25April2021) with partial black eye near the nose. So, was just wondered if there has been a reported side effect or should go to the doctor or what. The outcome of the event was unknown.  No follow-up attempts are needed; Information related to batch/Lot number could not be requested.
11/19/07  Received 4 month vaccinations (DTaP, Hib,Polio and Prevnar).  The same evening became diaphoretic and clammy with diarrhea and projectile vomiting.  Respirations were shallow with periods of apnea.  Cyanosis worsened as apneic periods increased.  Mom gave 2 rescue breaths. Became slightly more responsive. Was transported by squad to local hospital.  12/31/2007 MR received for DOD 11/20-21/2007 with D/C Dx:  Acute apneic episode likely 2' to esophageal reflux. Infant found lethargic, limp, diaphoretic and apneic by mom. Pt had an episode of projectile emesis and a loose, watery stool. Able to restore normal breathing with rescue breaths and stimulation.  Upon arrival in ED pt had revovered although had some desats to 92% while nursing. Admission PE WNL. No further incidents.
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. The patient's medical history and concurrent conditions were not reported. On 29-JUN-2016, the patient was inadvertently administered with M-M-R II, subcutaneously (dose, frequency and lot information were unspecified) that were improperly stored (incorrect product storage). No adverse effect reported. The outcome of the events was unknown. This is one of the several reports received from the same reporter. Additional information has been requested.
Pt recvd 3 doses of Engerix-B on 23JAN91, 20FEB91, & 10JUL91 & on 24OCT91 post HBSAB was 1.4RU which is interpreted as neg (no immunity);
Pt awoke 4 days after his vaccination with complete loss of hearing in the left ear, vertigo and nausea. CT scan of the head is negative. MRI/MRA pending. 12/26/07-records received consult 11/16/07-sudden loss of hearing left ear and vertigo with nausea and vomiting. Ataxic. CT Admitted for stroke evaluation.Incision of eardrum procedure. Balance improving as of 12/4/07 however hearing loss remains. Follow up in 1 year. Per 60 day follow up: Permanent deafness in left ear. Have there been any other reports of sudden sensorineural hearing loss/deafness after flu vaccine? 1/15/2010 Complete unilateral deafness.
At 3am , about 12 hours after the shot, I woke up with 101 fever. I was achy, sweaty and had a headache. I also vomited.   1.5 days later my lips are swelling and are very large.
Received Maderna #1 at 17:15 hours.  Developed a rash in her upper chest with itching - Lungs clear - No SOB - no stridor - Capillary refill intact. 140/82 - o2 Sat 99 - HR 75 Assessed by Dr. - Benadryl administered by physician - Ambulance transport at physician request to the ED
This case was reported by a consumer via call center representative and described the occurrence of rash in a 64-year-old patient who received SHINGRIX for prophylaxis. Previously administered products included ZOSTAVAX (about 2 years before the reporting time). On 5th April 2019, the patient received the 1st dose of SHINGRIX. On 7th April 2019, 2 days after receiving SHINGRIX, the patient experienced pain in arm, muscle pain and fatigue. On 8th April 2019, the patient experienced red rash and vesicular rash. In April 2019, the patient experienced rash and pain in arm. On an unknown date, the outcome of the rash, pain in arm, muscle pain, fatigue, pain in arm, red rash and vesicular rash were unknown. It was unknown if the reporter considered the rash, pain in arm, muscle pain, fatigue, pain in arm, red rash and vesicular rash to be related to SHINGRIX. Additional details were provided as follows: The patient had the expected achy arm. The patient had general muscle ache and fatigue before the day of reporting with the increased sore arm the patient at the time of reporting had a very red rash. This rash like area was about 2 inches below from the injection site going down about 6 inches below in a linear fashion. The reporter advised to get the 2nd dose in 3 months.
Injection at 1:30pm, by 4:00pm complained of fatigue, nausea. 4:45 complained of being cold, teeth chattered, shivered, thirsty. 5:00pm vomited once, the fever began 101.0. All symptoms resolved by 9:00pm
At 2:10 PM donor felt like, "head felt dizzy, legs felt like jello, and lightheaded." At  2:35 PM  Bp 98/68 pulse 68.
CHILLS FIRST NIGHT;  NEURALGIA AND JOINT ACHES NEXT 2 DAYS
Communication changes since May 2021 (not as talkative - more quiet). Difficulty concentrating since May 2021. Headaches during summer of 2021. Went through periods of silently talking to himself starting in the Summer and Fall of 2021.  I think this has since resolved itself.  Walked with a "hitch" for about a week following Moderna vaccination in December of 2021. Memory loss since vaccination, especially short-term memory. Current condition is memory and concentration problems.
Immediately after injection of 2 vaccines (1 on either arm) patient stood up to leave and within 1-3 minutes started to feel "not myself" "Felt dizzy".  pharmacist noted patient began to sweating profusely and rph told patient to sit down.  Blood pressure was read 46/23, after moving into consultation room blood pressure was 99/63 then 10 minutes later was 119/99
Covid-19 antibody test done at about 4 weeks after completing vaccine series show no COVID-19 antibodies; This spontaneous case was reported by a consumer and describes the occurrence of ANTIBODY TEST NEGATIVE (Covid-19 antibody test done at about 4 weeks after completing vaccine series show no COVID-19 antibodies) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024M20A and 045A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  .  Concomitant products included AMIODARONE, METOPROLOL TARTRATE, APIXABAN (ELIQUIS), ASPIRIN [ACETYLSALICYLIC ACID], OMEPRAZOLE (PRILOSEC [OMEPRAZOLE]), LISINOPRIL, MELATONIN, VITAMIN D [VITAMIN D NOS] and MULTIVITAMIN [VITAMINS NOS] for an unknown indication.   On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ANTIBODY TEST NEGATIVE (Covid-19 antibody test done at about 4 weeks after completing vaccine series show no COVID-19 antibodies). At the time of the report, ANTIBODY TEST NEGATIVE (Covid-19 antibody test done at about 4 weeks after completing vaccine series show no COVID-19 antibodies) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 antibody test: negative Negative.         No relevant concomitant medications were reported. No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not applicable.
Strange, prickly, itchy rash on my lower left side. And then it eventually it progressed to the middle of my back and partially to the right side. So that was the localized area. I had my dermatologist look at it. Then she saw that it looked like I had a rash on my chest, too. I didn't have itchiness there, though. And then she gave me betamethasone valerate (steroid ointment) and I applied that twice a day for three days. That seemed to clear that up. The itchiness went away. Nothing else in my lifetime had changed at that time other than the vaccine. The rough area of my skin on my left side feels normal again, too.
He was diagnosed with bilateral PE 11/8/2021 after he presented with shortness of breath .  He actually went to the cardiology office with his symptoms and D-dimer was checked and he was sent to the ER for evaluation of venous thromboembolism.  CT angio of the chest showed bilateral pulmonary emboli with moderate clot burden with a developing right heart strain, bilateral thyroid nodules pulmonary opacities.  Duplex of the lower extremities showed posterior tibial vein and peroneal vein DVT on the left side.  He had no obvious provoking factors prior to the onset of symptoms like immobilization, surgery, long travel or use of hormone therapy.   He did receive Covid booster vaccine on 10/26/2021 and then the symptoms developed.  He also reported similar symptoms of shortness of breath after he received the initial Covid vaccine in December 2020.
On 8/21/06 pt age 8 yrs received a Tdap instead of a TD. Pt had not received a Dtap for kindergarten but was too young for Tdap and too old for the Dtap. No reaction to vaccine were reported.
J96.00 ACUTE RESPIRATORY FAILURE 9/9/2022 OTH DSPLCD FX UPPER END RT HUM INIT ENC CLOS FX J96.91 HYPOXEMIC RESPIRATORY FAILURE, UNSPECIFIED ACUITY 9/9/2022 OTH DSPLCD FX UPPER END RT HUM INIT ENC CLOS FX
broken right wrist; broken right foot; This is a spontaneous report from a contactable consumer reporting for herself. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot Number: ER2613; Expiration date was not reported), via an unspecified route of administration on 22Mar2021 as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced broken right wrist, broken right foot on an unspecified date. For lot number, caller stated the only numbers she sees on the card is ER2613 and DGM4. Caller stated she received the COVID vaccine yesterday and she had a question. Caller stated the nurse kept saying she could not take Advil and she had broken her right wrist and right foot. Caller stated it helped to take Advil in between taking Percocet. Caller stated her pharmacist said she could take Advil. Caller wants to know if she could take Advil or not. Caller stated her COVID 19 vaccine card was in her purse and she had to go get it but will also need her glasses. Caller apologized as she was slower than normal because of her broken foot. Caller stated so this agent was telling her that she has been on hold for 45 minutes and she had to be on hold again since this agent cannot answer her question. Caller declined to complete report at this time wished to be transferred for her question. Caller unwilling to complete the report. Clinical outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
- Fever starting Saturday, 8/3/19 ending Saturday 8/3/19 bedtime (approximately 11:00 PM) accompanied by muscle  and joint ache (typical with fever) - redness, heat, and skin sensitivity in area of injection extending approximately 2" around injection site starting 8/3/19, as of today, 8/6/19 size of affected area and sensitivity have diminished by about half of that on Sunday,
BLINDNESS; This spontaneous report received from a contact concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, 1 total, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced blindness. No other information was provided. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of blindness was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20210637236-covid-19 vaccine ad26.cov2.s-blindness. This event(s) is considered unassessable. The event(s) has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Severe headache, fever, fatigue, body aches, injection site pain/ tenderness - all treated with NSAID and disappeared after 30hrs post injection
Patient arrived for 2:20 pm appointment.  Patient care technician (PCT) collected ID/insurance and registered patient.  During registration, patient filled out vaccine consent form and signed.  Appointment was listed as "Other- COVID scheduling" but no specific vaccine was was listed in the details.  NP was finishing a meeting with the Clinic Manager and additional patients were arriving to register.  NP called patient back at approximately 2:30 pm and verified name and DOB. NP reviewed consent  with patient and told him that this would be the second dose and reviewed possible side effects.  However, NP does not recall whether she mentioned the specific vaccine he was receiving today when she was reviewing the second dose side effects with patient.  NP glanced at vaccine card and saw a 1st dose sticker with a date of 5/2/21 and although, past the 42 day range, NP believed recommendations  were still to vaccinate.  Therefore, NP placed Pfizer sticker on vaccine card, dated and signed.  However, NP did not verify the manufacturer of the first dose when she looked a patient's card.  0.3 mL of Pfizer was given to patient in his right deltoid.  Patient remained in waiting area for 15 minutes as recommended and then left with no adverse reactions.  At approximately, 3:45 p.m, Patient returned to clinic to inform NP that his card showed a first dose of Moderna and now second dose of Pfizer.  NP reviewed card and verified in patient's chart that he had reieved Moderna 0.5 mL on 5/2/21 and now Pfizer 0.3 mL on 7/1/21.  NP admitted to this being her error and asked patient to remain seated while she contacted her manager.  Clinic manager was notified and also notified clinic director.  NP was instructed to place a  VAERS report and occurrence report.  As of this time, patient has experienced no adverse side effects and reports no physical complaints.  Moderna Mfr was contacted by but they were unable to provide guidance on patient's next steps.  CDC Administration Errors and Deviations document reviewed which indicated that patient not receive another dose of either Moderna or Pfizer.  Patient was contacted to follow up and instructed to not receive any additional doses per the CDC document.
Red, sore injection site. Erythema area: 4 1/2 inches x 6 inches. Headache, stomach ache, fatigue.  Unable to perform normal activities. Took Tylenol and went to bed. So far this is within 24 hours of injection.